Blue Ash Therapeutics' Seed VC Round

Blue Ash Therapeutics raised a round of funding on April 22, 2010.

Blue Ash Therapeutics, LLC was formed in December 2008 in Cincinnati to bring a cardiovascular drug " azimilide - to market. Azimilide is an oral once-daily cardiac antiarrhythmic (AA) drug for use in…

Articles about Blue Ash Therapeutics' Seed VC Round: